China SXT Pharmaceuticals Inc. (NASDAQ:SXTC) shares, rose in value on Friday, 05/13/22, with the stock price up by 6.71% to the previous day’s close as strong demand from buyers drove the stock to $0.17.
Actively observing the price movement in the last trading, the stock closed the session at $0.16, falling within a range of $0.1551 and $0.17. The value of beta (5-year monthly) was 0.24. Referring to stock’s 52-week performance, its high was $2.28, and the low was $0.11. On the whole, SXTC has fluctuated by -27.07% over the past month.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that SXTC’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of SXTC currently trading nearly -15.32% and -21.23% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.16, while the 7-day volatility ratio is showing 17.24% which for the 30-day chart, stands at 13.56%. Furthermore, China SXT Pharmaceuticals Inc. (SXTC)’s beta value is 0.45, and its average true range (ATR) is 0.03.
Data on historical trading for China SXT Pharmaceuticals Inc. (NASDAQ:SXTC) indicates that the trading volumes over the past 10 days have averaged 1.3 million and over the past 3 months, they’ve averaged 9.25 million. According to company’s latest data on outstanding shares, there are 15.55 million shares outstanding.
Nearly 12.11% of China SXT Pharmaceuticals Inc.’s shares belong to company insiders and institutional investors own 4.80% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.49 million shares as on Feb 14, 2022, resulting in a short ratio of 0.07. According to the data, the short interest in China SXT Pharmaceuticals Inc. (SXTC) stood at 1.67% of shares outstanding as of Feb 14, 2022; the number of short shares registered in Jan 13, 2022 reached 0.19 million. The stock has fallen by -74.57% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SXTC stock heading into the next quarter.